Stay updated on Nivolumab in ER+ Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.

Latest updates to the Nivolumab in ER+ Breast Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check12 days agoChange DetectedAdded Padova, Italy 35128 and removed Padua, Italy 35128 from the study locations.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedNapoli, Italy, 80131 was replaced with Naples, Italy, 80131 in the study locations.SummaryDifference0.0%

- Check34 days agoChange DetectedRevision updated to v3.5.0; previous revision v3.4.3 was removed.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision tag on the page changed from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check69 days agoChange DetectedAdded Revision: v3.4.2. Removed the government funding lapse notice and the prior Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in ER+ Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in ER+ Breast Cancer Clinical Trial page.